Clinical Trial Update: MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I [Phase 4]

View source ↗

Summary

The MINT I trial, a multi-institutional Phase 4 study evaluating neo-adjuvant therapy guided by the MammaPrint assay in breast cancer, has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Agendia | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED